Eric Lefkofsky the Co-Founder and CEO of Tempus an Operating System and Technology Company with the intention to battle Cancer are building a library of data to recognize genes and particular mutations in each individual. The Company and its operating system for Oncologists will help them to treat lung cancer, melanoma, bladder and breast cancer, lymphoma and endocrine therapy. Consequently, it will be easier to recognize the illness and how to treat each patient.
Mr. Eric Lefkofsky thinks that patients have to be treated differently and depending on that mutation, doctors can recommend that specific drugs that better assist them in the treatment of Cancer. Each person is different and his or hers genes differ from each other.
Therefore, targeting those genes and with early detection, like screening, scans, and medication, the patients with Cancer will have less expensive treatments.
The Company has a genomic sequencing Lab to process more than 50,000 patients annually.
Tempus and Eric Lefkofsky have partnered with Mayo Clinic to help doctors use that data treat patients with Cancer.
They did the same with Rush University Medical, and Northwestern University’s Robert H. Lurie Comprehensive Cancer Center.
Eric Lefkofsky and his wife have established a private Family Foundation, he is an adjunct professor at the University of Chicago, he graduated from the University of Michigan.
A dream come true, the challenge of Eric Lefkofsky is to prevent, research, and treat the sick with clinical studies that combined with his data can give patients with Cancer a better chance to fight this illness.
The probability of losing someone with cancer or have lost a loved one with this devastating illness exists and Eric Lefkofsky with his understanding and knowledge and how important is to have the data before treatment will give millions hope to reduce the probabilities and to improve the health of the population all over the world.